Inhibition of the Hedgehog pathway, particularly targeting the activator smoothened (SMO) using small interfering RNA (siRNA) and the small molecule inhibitor NVP-LDE-225, has been effective in curbing melanoma growth in vitro. Here, SMO is linked to melanoma.